Dr. Steinberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1725 W Harrison ST, STE 970
Chicago, IL 60612Phone+1 312-947-3447
Education & Training
- Johns Hopkins UniversityResidency, Urology, 1987 - 1991
- Johns Hopkins UniversityResidency, Surgery, 1985 - 1987
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1985
- Johns Hopkins UniversityB.A., 1981
Certifications & Licensure
- IL State Medical License 1994 - 2026
- NY State Medical License 2019 - 2024
- NJ State Medical License 1991 - 1995
- MD State Medical License 1988 - 1993
- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Best Doctors US News and World Report, 2011
- Best Doctors in America 2010
- Join now to see all
Clinical Trials
- Surgery in Treating Patients With Prostate Cancer Start of enrollment: 1997 May 01
- Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit Start of enrollment: 2010 Mar 01
- Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer Start of enrollment: 2014 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsBladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Se...Roger Li, Patrick J Hensley, Shilpa Gupta, Hikmat Al-Ahmadie, Marko Babjuk
European Urology. 2024-12-01 - Urachal Carcinoma: Insights From a National Database.Angelo Orsini, Gabriele Bignante, Francesco Lasorsa, Eugenio Bologna, Spencer M Mossack
Clinical Genitourinary Cancer. 2024-12-01 - Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer.Jacob I Taylor, Ashish M Kamat, Michael A O'Donnell, Drupad Annapureddy, Jeffrey Howard
BJU International. 2024-08-25
Journal Articles
- Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USASiamak Daneshmand, Anne K. Schuckman, Bernard H. Bochner, Michael S. Cookson, Tracy M. Downs, Leonard G. Gomella, H. Barton Grossman, Ashish M. Kamat, Badrinath R. Kon..., Nat. Rev. Urol, 1/23/2014
- Gender disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigationJoshua A. Cohn, M.D., Benjamin Vekhter, Ph.D., Christopher Lyttle, M.S., Gary D. Steinberg, M.D., and Michael C. Large, M.D, Cancer, 1/1/2014
- Alvimopan, a Peripherally Acting Mu-Opioid Receptor Antagonist, Is Associated With Reduced Costs After Radical Cystectomy? Economic Analysis of a Phase 4 Randomized, C...Teresa L. Kauf, PhD1; Robert S. Svatek, MD2; Gilad Amiel, MD3; Timothy L. Beard, MD4; Sam S. Chang, MD5; Amr Fergany, MD6; R. Jeffrey Karnes, MD7; Michael Koch, MD8; J..., The Journal of Urology, 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Clinical Evaluation of Cisplatin Sensitivity Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial CancerPeter H. O'Donnell, Ilana R. Garcia-Grossman, Hongyuan Cao, Irina Ostrovnaya, Elizabeth R. Plimack, Kelly L. Stratton, Christopher Manschreck, Norm D. Smith, Gary D. S..., GU ASCO Meeting, San Francisco, CA, 1/30/2014
- Phase I/II study of vesigenurtacel-L (HS-410) or placebo in combination with Bacillus Calmette-Guerin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC)Steinberg G, Shore N, Karsh L, Bailen J, Woods M, Schoenberg M, Schreiber TH and Price M, Society for Immunotherapy of Cancer Meeting, Washington, DC, 1/7/2014
- Alvimopan, a peripherally acting mu-opiod receptor antagonist, accelerates gastrointestinal recovery and decreases length of hospital stay after radical cystectomyKamat A, Chang S, Lee C, Amiel G, Beard T, Fergany A, Karnes J, Menon V, Sexton W, Slaton J, Svatek R, Wilson S, Techner L, Bihrle R, Koch M, Steinberg G, AUA meeting, San Diego, CA, 1/7/2013
- Join now to see all
Lectures
- Options for bladder cancer patients undergoing radical cystectomyNashville, TN - 1/23/2014
- Non-muscle invasive and Muscle invasive bladder cancerClinica Alemana, Santiago, Chile - 1/13/2014
- High risk Non Muscle Invasive Bladder CancerColumbia University, New York, NY - 1/28/2013
- Join now to see all
Other
- Bladder CancerSteinberg GD, Brosman SA, Curti B, et al, eMedicine from WebMD
http://emedicine.medscape.com/article/438262-overview
1/29/2011 - Transurethral Resection of Bladder TumorsSteinberg GD, Sachdeva K, Curti B, Katz MH, Jana BR, eMedicine from WebMD
http://emedicine.medscape.com/article/1951622-overview
1/29/2011 - Bacillus Calmette-Guerin Immunotherapy for Bladder CancerSteinberg GD, Sachdeva K, Curti B, Katz MH, Jana BR, eMedicine from WebMD
http://emedicine.medscape.com/article/1950803-overview
1/29/2011 - Join now to see all
Press Mentions
- Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder CancerDecember 5th, 2024
- Aura Biosciences Reports Third Quarter 2024 Financial Results and Business HighlightsNovember 12th, 2024
- Gary Steinberg, MD, on Next Steps for Clinical Development of Bel-Sar in NMIBCOctober 30th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: